Adalimumab Outperforms Standard Therapy in Uveitis Study

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to rely on corticosteroids when they receive adalimumab instead of conventional agents.
Medscape Medical News